✦ LIBER ✦

Prognostic impact of electrocardiographic signs in patients with Type 2 diabetes and cardiovascular disease: results from the PROactive study

✍ Scribed by R. Pfister; R. Cairns; E. Erdmann; C. A. Schneider; on behalf of the PROactive investigators

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pioglitazone and the risk of cardiovascu

✍ Erland ERDMANN; Robert SPANHEIMER; Bernard CHARBONNEL; on behalf of the PROactiv 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB

The Effect of Pioglitazone on Recurrent

✍ Erland Erdmann; John A. Dormandy; Bernard Charbonnel; Massimo Massi-Benedetti; I 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Factors Predictive of Cardiovascular Dis

✍ Xavier Pintó; Emili Corbella; Rosaura Figueras; Josefina Biarnés; Wifredo Ricart 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Cost-effectiveness of primary prevention

✍ M. Raikou; A. McGuire; H. M. Colhoun; D. J. Betteridge; P. N. Durrington; G. A. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 181 KB

Gender disparities in diabetes and coron

✍ Heike U Krämer, Elke Raum, Gernot Rüter, Ben Schöttker, Dietrich Rothenbacher, T 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 205 KB

Prognostic Impact of the Presence and Ab

✍ Dagenais, Gilles R.; Lu, Jiang; Faxon, David P.; Bogaty, Peter; Adler, Dale; Fue 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 1010 KB